Ultromics
Ultromics

Ultromics

Using AI to augment echocardiography – detecting heart disease earlier

Heart disease is the world’s leading cause of death, yet many forms remain difficult to diagnose early.

Ultromics uses AI to analyse routine echocardiograms with greater speed and accuracy, helping clinicians detect and treat heart failure sooner and better. Spun out of Oxford and founded by sonographer and PhD graduate Ross Upton, the company is turning everyday scans into lifesaving insights, supporting earlier intervention and more informed treatment decisions.

Sector
HealthTech
Stage
  • Series B+
OSE Manager Limited, a wholly owned subsidiary of Oxford Science Enterprises plc, is authorised and regulated by the Financial Conduct Authority.